Published in Br J Pharmacol on February 01, 2002
CD39 and CD73 in immunity and inflammation. Trends Mol Med (2013) 2.08
P2 receptors in cardiovascular regulation and disease. Purinergic Signal (2007) 1.91
Purinergic signalling. Br J Pharmacol (2006) 1.83
Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways. Thromb Haemost (2005) 1.38
The adventitia: essential regulator of vascular wall structure and function. Annu Rev Physiol (2012) 1.31
Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death Dis (2010) 1.19
Purinergic mechanism in the immune system: A signal of danger for dendritic cells. Purinergic Signal (2005) 1.10
Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. Am J Physiol Cell Physiol (2008) 1.09
Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms. J Biol Chem (2010) 1.05
Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells. Angiogenesis (2007) 1.01
Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice. Gastroenterology (2007) 1.00
Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. Am J Physiol Heart Circ Physiol (2008) 0.99
P2 receptors and platelet function. Purinergic Signal (2011) 0.98
ATP and UTP responses of cultured rat aortic smooth muscle cells revisited: dominance of P2Y2 receptors. Br J Pharmacol (2003) 0.94
Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice. Br J Pharmacol (2006) 0.93
Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors. J Mol Cell Cardiol (2005) 0.91
P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice. Br J Pharmacol (2009) 0.90
A common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular events. PLoS One (2012) 0.90
Purinergic receptors and nucleotide processing ectoenzymes: Their roles in regulating mesenchymal stem cell functions. World J Stem Cells (2014) 0.89
A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes. Mol Cells (2015) 0.87
Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells. Exp Mol Med (2008) 0.87
Mechanisms of Platelet Activation and Integrin αIIβ3. Korean Circ J (2012) 0.85
P2 receptors in atherosclerosis and postangioplasty restenosis. Purinergic Signal (2007) 0.84
Extracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein secretion. PLoS One (2012) 0.84
Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty. J Thromb Haemost (2008) 0.84
The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells. PLoS One (2015) 0.83
Variable impact of CD39 in experimental murine colitis. Dig Dis Sci (2010) 0.82
Deletion of P2Y2 receptor reveals a role for lymphotoxin-α in fatty streak formation. Vascul Pharmacol (2016) 0.80
Regulation of innate immunity by extracellular nucleotides. Am J Blood Res (2013) 0.79
P2 receptors in atherosclerosis and postangioplasty restenosis. Purinergic Signal (2006) 0.79
P2Y6 receptor-mediated proinflammatory signaling in human bronchial epithelia. PLoS One (2014) 0.78
P2X(7) Receptors in Neurological and Cardiovascular Disorders. Cardiovasc Psychiatry Neurol (2009) 0.78
Short- and long-term (trophic) purinergic signalling. Philos Trans R Soc Lond B Biol Sci (2016) 0.78
Shaping immune responses through the activation of dendritic cells' P2 receptors. Purinergic Signal (2006) 0.76
P2X receptors regulate adenosine diphosphate release from hepatic cells. Purinergic Signal (2014) 0.76
Purinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells: NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR. J Biol Chem (2015) 0.76
20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells. Br J Pharmacol (2011) 0.75
Adenosine 5'-triphosphate stimulates the increase of TGF-beta1 in rat mesangial cells under high-glucose conditions via reactive oxygen species and ERK1/2. Acta Pharmacol Sin (2009) 0.75
The Impact of Vitamin D3 Supplementation on Mechanisms of Cell Calcium Signaling in Chronic Kidney Disease. Biomed Res Int (2015) 0.75
Invited Lectures : Overviews Purinergic signalling: past, present and future. Purinergic Signal (2006) 0.75
Receptors for purines and pyrimidines. Pharmacol Rev (1998) 13.92
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell (1998) 7.46
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science (1996) 7.10
Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (1991) 5.76
Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem (2001) 5.74
Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (2001) 5.51
Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med (1997) 5.35
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med (1999) 4.44
Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem (1994) 4.17
Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol (2000) 4.06
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci (2000) 3.70
Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol (2000) 3.44
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev (2001) 3.26
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol (1997) 2.81
Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem (1996) 2.79
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem (1997) 2.78
An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb (1993) 2.77
Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet (1998) 2.77
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76
Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature (2000) 2.73
Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol (1996) 2.68
Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol (2000) 2.56
The combined role of P- and E-selectins in atherosclerosis. J Clin Invest (1998) 2.53
Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med (1997) 2.52
Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. Circulation (1990) 2.38
Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J (2001) 2.34
The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today (1995) 2.31
Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides. J Biol Chem (1989) 2.23
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest (1997) 2.18
Identification of a novel human ADP receptor coupled to G(i). J Biol Chem (2001) 2.05
Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat (1999) 1.94
Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol (1999) 1.94
P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther (2000) 1.85
Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. Proc Natl Acad Sci U S A (1991) 1.79
Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev (2001) 1.76
Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br J Pharmacol (1991) 1.75
Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol (1984) 1.74
The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest (1995) 1.73
Novel risk factors for atherosclerosis. Mayo Clin Proc (2000) 1.70
The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett (1997) 1.70
Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis (1989) 1.69
P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem (2001) 1.63
Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62
Quantitation of extracellular UTP using a sensitive enzymatic assay. Br J Pharmacol (1999) 1.61
P2 receptor subtypes in the cardiovascular system. Biochem J (1998) 1.60
Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis. Circulation (2000) 1.51
Cytolytic P2X purinoceptors. Cell Death Differ (1998) 1.50
Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res (1994) 1.50
cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J Biol Chem (1994) 1.46
Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J Cell Biol (1997) 1.46
Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. J Immunol (1996) 1.41
Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors. Am J Physiol Cell Physiol (2000) 1.40
Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol (2000) 1.38
Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci U S A (2000) 1.36
Ecto-nucleotidases--molecular structures, catalytic properties, and functional roles in the nervous system. Prog Brain Res (1999) 1.34
Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood (1998) 1.34
An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transduction. J Cell Biol (2001) 1.34
Subcellular distribution studies of diadenosine polyphosphates--Ap4A and Ap5A--in bovine adrenal medulla: presence in chromaffin granules. J Neurochem (1988) 1.32
P2X(4) receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol Heart Circ Physiol (2000) 1.31
Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br J Pharmacol (1997) 1.30
Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci (1999) 1.29
Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism. J Immunol (1999) 1.27
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood (1996) 1.26
CD39 modulates endothelial cell activation and apoptosis. Mol Med (2000) 1.25
Link between infection and atherosclerosis: who are the culprits: viruses, bacteria, both, or neither? Circulation (2001) 1.25
Distribution of P2Y receptor subtypes on haematopoietic cells. Br J Pharmacol (1998) 1.25
Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol (1998) 1.24
Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP. Br J Pharmacol (1998) 1.24
ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochem Int (1998) 1.24
Stimulation of vascular prostacyclin synthesis by extracellular ADP and ATP. Biochem Biophys Res Commun (1983) 1.22
Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci (1995) 1.20
Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci (1998) 1.19
Receptors for ADP on human blood platelets. Trends Pharmacol Sci (1994) 1.18
Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem (1998) 1.17
Influence of external ATP on permeability and metabolism of dog red blood cells. Am J Physiol (1972) 1.17
Cellular pathology of atherosclerosis: smooth muscle cells prime cocultured endothelial cells for enhanced leukocyte adhesion. Circ Res (2001) 1.16
P2X7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ Res (1998) 1.16
Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes (1996) 1.16
Genetic aspects of arteriosclerosis. Arteriosclerosis (1986) 1.16
Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis. Biochem Biophys Res Commun (1998) 1.15
Apparent species differences in the kinetic properties of P2X(7) receptors. Br J Pharmacol (2000) 1.14
ATP stimulates secretion in human neutrophils and HL60 cells via a pertussis toxin-sensitive guanine nucleotide-binding protein coupled to phospholipase C. FEBS Lett (1989) 1.13
Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J (2001) 1.13
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem (1996) 1.12
Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation (1996) 1.12
Nitric oxide is the mediator of ATP-induced dilatation of the rabbit hepatic arterial vascular bed. Br J Pharmacol (1991) 1.12
P2X7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J Immunol (2001) 1.09
ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase. Nature (1979) 1.09
Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett (1999) 1.07
Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: implications for inflammatory gene expression. J Neurosci (2001) 1.06
The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J (2000) 1.06
Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 alpha and IL-1 beta occurs via a similar mechanism. J Immunol (1998) 1.03
Endotoxin activation of macrophages does not induce ATP release and autocrine stimulation of P2 nucleotide receptors. J Immunol (2000) 1.03
Comparative study of platelet dense granule constituents. Am J Physiol (1982) 1.03
Hypotonic stress-induced dual Ca(2+) responses in bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol (2000) 1.03
Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747. Br J Pharmacol (2001) 1.02
P2X receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J Vasc Res (2001) 1.01
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects. Nat Rev Endocrinol (2012) 1.73
Pattern of expression of inflammatory markers in adipose tissue of untreated hypertensive patients. J Hypertens (2010) 1.43
Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc Diabetol (2013) 1.33
HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care (2013) 1.31
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens (2011) 1.26
TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes (2009) 1.26
Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP. Eur J Neurosci (2007) 1.16
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes. Atherosclerosis (2011) 1.11
Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) study. Nephrol Dial Transplant (2011) 1.08
Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care (2012) 1.06
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis (2007) 0.98
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc Diabetol (2014) 0.92
Effect of a fatty meal on inflammatory markers in healthy volunteers with a family history of type 2 diabetes. Br J Nutr (2011) 0.89
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters. J Clin Endocrinol Metab (2008) 0.88
The complex P2X7 receptor/inflammasome in perivascular fat tissue of heavy smokers. Eur J Clin Invest (2014) 0.84
PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates. Diabetes Care (2003) 0.83
High prevalence of advanced retinopathy in patients with type 2 diabetes from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Res Clin Pract (2012) 0.83
Selective insulin resistance affecting nitric oxide release but not plasminogen activator inhibitor-1 synthesis in fibroblasts from insulin-resistant individuals. Arterioscler Thromb Vasc Biol (2005) 0.82
Antihypertensive treatment and multifactorial approach for renal protection in diabetes. J Am Soc Nephrol (2005) 0.81
Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome? Atherosclerosis (2011) 0.81
Increased sensitivity to extracellular ATP of fibroblasts from patients affected by systemic sclerosis. Ann Rheum Dis (2007) 0.81
Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype. Endocrinology (2009) 0.80
RAS blockade for every diabetic patient: pro and con. Diabetes Care (2011) 0.79
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition. Eur Heart J (2011) 0.79
P2X7 receptor polymorphisms do not influence endothelial function and vascular tone in neo-diagnosed, treatment-naive essential hypertensive patients. J Hypertens (2013) 0.77
Extracellular adenosine 5'-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. Endocrinology (2005) 0.77
Hypothyroidism and intermediate metabolism: a complex relationship. Thyroid (2010) 0.76
Correspondence between the International Diabetes Federation criteria for metabolic syndrome and insulin resistance in a cohort of Italian nondiabetic Caucasians: the GISIR database. Diabetes Care (2007) 0.75
Soluble CD40 ligand levels in essential hypertensive men: evidence of a possible role of insulin resistance. Am J Hypertens (2009) 0.75
Metabolic and Hormonal Determinants of Glomerular Filtration Rate and Renal Hemodynamics in Severely Obese Individuals. Obes Facts (2016) 0.75